Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

SPF 50 Sunscreen Formulation and Manufacturing

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract calls for the manufacture of SPF 50 sunscreen with a precise formulation containing 4.5% titanium dioxide and 4% zinc oxide, formulated to meet stringent FDA and federal regulatory standards for safety and efficacy. Each finished unit must be packaged in quantities of 24 tubes per package, ensuring consistent distribution and usability in field conditions. The product is intended for military use and must adhere to all applicable quality control protocols to guarantee performance under extreme environmental conditions. This is a subcontract opportunity issued under the NAICS code 325612 for cosmetic and toilet preparation manufacturing, sponsored by the Department of Defense through the Medical Supply Chain Pharm FSA. The contract requires delivery to Fort Bragg, North Carolina, with a response deadline of July 27, 2026, and was posted on July 19, 2026. Bidders must demonstrate compliance with all federal specifications and have the capacity to deliver the required quantities under the defined packaging and labeling standards. The contract does not specify a set-aside designation, and interested parties must submit proposals through the DIBBS portal.

General Info

Manufacture SPF 50 sunscreen with 4.5% titanium dioxide and 4% zinc oxide, packaged 24 tubes per unit, for military use at Fort Bragg by July 27, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325612 - Polish and Other Sanitation Good ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufacture of SPF 50 sunscreen containing 4.5% titanium dioxide and 4% zinc oxide, packaged 24 tubes per package, compliant with FDA and federal standards.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
Medical Chemical Formulation and ManufacturingThe contract involves the manufacture of a modified 0.125 percent sodium hypochlorite solution, known as Dakins Solution Quarter Strength, packaged in 480 mL bottles. The scope includes full formulation development, rigorous quality control protocols, batch-by-batch testing to ensure consistency and safety, and strict compliance with medical-grade standards to meet regulatory requirements for clinical use. All production activities must adhere to guidelines ensuring sterility, stability, and purity, as the final product is intended for medical applications requiring precise chemical concentrations and contamination-free packaging. The contract is classified as a subcontract under NAICS code 325412 for pharmaceutical and medicine manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on July 20, 2026, with a response deadline of July 27, 2026, and the performance location is not specified, implying flexibility in manufacturing site selection as long as compliance and delivery standards are met. The solicitation is accessible through the DIBBS platform, and while no set-aside provisions or point of contact information is provided, bidders are expected to demonstrate proven capability in producing pharmaceutical-grade chemical solutions with validated quality systems and documented adherence to medical manufacturing regulations.
Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

in 7 days
View Details